Parkinson’s Expert Offers Tips About Enduring the COVID-19 Pandemic
An estimated one million Americans have Parkinson’s disease. Nobody knows how many of them also are infected with COVID-19, but…
Articles by Larry Luxner
Dutch Neurologist Warns of ‘Parkinson’s Pandemic’ Linked to Toxic Chemicals
As the world frantically battles coronavirus, a leading Dutch neurologist warns of the next global pandemic — and this one,…
Neurosteer Promotes Wearable Monitor to Detect Early Parkinson’s
Within a few years, doctors will be able to remotely evaluate patients for their risk of developing Alzheimer’s disease,…
Israeli Scientist’s Robotics Research May One Day Help Parkinson’s Patients
For years, Israeli neurologist Tamar Flash has had a fascination with the octopus, and the way the invertebrate’s eight arms…
Parkinson’s Foundation Will Gather Experts to Study Cannabis as Disease Therapy
These days, people with Parkinson’s disease tend to ask their doctors more questions about cannabis than any other subject; yet,…
Medical Marijuana ‘Can Help Everyone,’ Says Director at Maryland Cannabis Facility
Warning the reporter accompanying him not to take any pictures, veteran horticulturalist Michael Castleman punches an electronic code and unlocks…
Parkinson’s Foundation Adds 3 Centers of Excellence to Its Network
Ohio’s Cleveland Clinic will officially become a Parkinson’s Foundation Center of Excellence on Oct. 2, followed by the Medical…
Benefits of Acadia’s Nuplazid Outweigh Risks for Parkinson’s Psychosis Patients, FDA Reports
Nearly half a year after news reports surfaced about deaths allegedly linked to Nuplazid (pimavanserin) — a therapy for Parkinson’s…
FDA Continuing to Monitor Nuplazid Use, Agency Says in Response to Controversial CNN Report
The U.S. Food and Drug Administration is keeping close watch on the use of Nuplazid (pimavanserin)Â by Parkinson’s patients with…